Growing Prevalence of Pharmerging Market - Analysis, Size, Share, Segments, Growth, Trends, and Forecast 2016 - 2024
About
Pharmerging
Market
Global
Pharmerging Market: Overview
This
report on pharmerging market studies the current as well as future
prospects of the market globally. The stakeholders of this report
include companies and intermediaries engaged in the manufacture and
commercialization of various pharmaceutical products as well as new
entrants planning to enter this market. This report comprises an
elaborate executive summary along with a market snapshot providing
overall information of various segments and sub-segments considered
within the scope of the study. This section also provides the overall
information and data analysis of the global pharmerging market with
respect to the leading market segments based on major products,
applications and geographies.
The
market overview section of the report explores the market dynamics
such as drivers, restraints, and opportunities that currently have a
strong impact on the global pharmerging market and could influence
the market in the near future. Market attractiveness analysis has
been provided in all the sections of the report in order to explain
the intensity of competition in the market across different
products/materials/technologies/end-users/geographies. The
competitive scenario among different market players is evaluated
through market share analysis in the competition landscape section of
the report. The section also includes competition matrix that
analyzes the competition among some of the top global players
operating in the market. All these factors would help market players
to take strategic decisions in order to strengthen their positions
and expand their shares in the global market.
Get
Sample Copy of this report @
Global
Pharmerging Market: Segmentation
The
global pharmerging market is divided into: by product, by economic
growth levels, by distribution channel and by geography. Product type
segment of pharmerging market was divided into Pharmaceuticals
(Branded Prescription Drugs, Generic Drugs (Branded Generics,
Unbranded Generics), and OTC Drugs) and Healthcare (Medical Devices,
and Diagnostic Instruments, Others (IT and record management)). On
the basis of Economic Growth Levels the market was divided as - Tier
– 1, Tier – 2 and Tier – 3). On the basis of distribution
channel the pharmerging market is divided as hospitals, clinics,
retail pharmacies, e-commerce, and drug stores.
The
market for these segments has been extensively analyzed based on
their utility, effectiveness, sales, and geographic presence. Market
revenue in terms of US$ Mn and market volume in terms of units for
the period from 2016 to 2024 along with the compound annual growth
rate (CAGR %) from 2016 to 2024 are provided for all segments,
considering 2016 as the base year.
View
Report @
Geographically,
the pharmerging market has been segmented into five regions: North
America, Europe, Asia Pacific, Europe, Middle East & Africa
(MEA), and Latin America. Each regional market for pharmerging market
has been further categorized into major product, applications,
material, and end-user segments considered within the scope of the
study. Key country (U.S., Canada, Japan, Germany, France, U.K.,
Australia, Canada, China, Brazil, Mexico, India, etc.) market
revenues have also been provided in different regional sections
within the report. Market revenue in terms of US$ Mn and volume in
terms of units for the period from 2014 to 2025 along with CAGR %
from 2016 to 2025 are provided for all the regions and nations
considering 2016 as the base year.
Companies
Mentioned in the Research Report
The
report profiles key manufacturers in the pharmerging market based on
various attributes such as company details, SWOT analysis, strategic
overview, financials, and business overview. Major players profiled
in this report include Abbott Laboratories, Koninklijke Philips N.V.,
F. Hoffmann-La Roche Ltd., Merck & Co., Inc., Novartis AG,
Johnson & Johnson, Teva Pharmaceutical Industries Ltd.,
AstraZeneca, GlaxoSmithKline plc., LUPIN, Tata Consultancy Services
Limited, Sun Pharmaceutical Industries Ltd., Huadong Medicine Co.,
Ltd., etc.
The
global pharmerging Market has been segmented as follows:
By
Product Type
Pharmaceuticals
Branded Prescription Drugs
Generic Drugs
Branded Generics
Unbranded Generics
OTC Drugs
Healthcare
Medical Devices
Diagnostic Instruments
Others (IT and record management)
By
Indications
Lifestyle Diseases
Cancer and autoimmune diseases
Infectious Diseases
Others
By
Distribution Channel
Hospitals
Clinics
Retail Pharmacies
E-commerce
Drug Stores
By
Region
Europe
Asia Pacific
Latin America
Middle East and Africa
Table
of Content
Section
01 Preface
1.1.
Report Scope and Market Segmentation
1.2.
Research Highlights
Section
02 Assumptions and Research Methodology
2.1.
Assumptions and Acronyms Used
2.3.
Research Methodology
Section
03 Executive Summary
3.1.
Global Pharmerging Market Snapshot
Section
04 Market Overview
4.1.
Product Overview
4.2.
Key Industry Developments
Section
05 Market Dynamics
5.1.
Opportunity Analysis
5.2.
Drivers and Restraints Snapshot Analysis
5.3.
Drivers
5.3.1.
Continuous Research and Development
5.3.2.
Increasing Government Expenditure on Healthcare
5.3.3.
Rising non-communicable diseases (NCDs)
5.3.4.
Free trade agreement
5.3.5.
Growing income
5.3.6.
Aging population and increasing life expectancy
5.4.
Restraints
5.4.1.
Economic challenges in Africa
5.4.2.
Weak or ambiguous patent laws
5.4.3.
Growing medical tourism
5.4.4.
Partnerships and acquisition of local players by MNCs
5.5.
Porter’s Analysis
5.6.
Value Chain Analysis (Medical Devices)
5.7.
Value Chain Analysis (Pharmaceuticals)
5.8.
Mergers and Acquisitions Landscape
5.9.
Reimbursement Scenario
5.10.
Pharmerging Market Outlook
About
us
MarketResearchReports.biz
is the most comprehensive collection of market research reports.
MarketResearchReports.Biz services are specially designed to save
time and money for our clients. We are a one stop solution for all
your research needs, our main offerings are syndicated research
reports, custom research, subscription access and consulting
services. We serve all sizes and types of companies spanning across
various industries.
Contact
Mr.
Nachiket
State
Tower
90
Sate Street, Suite 700
Albany,
NY 12207
Tel:
+1-518-621-2074
Comments
Post a Comment